Year-End Termination

KING & SPALDING LLP for UCB PHARMA INC

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Pharmaceutical issues

LobbyistCovered position, as disclosed
ALLISON F KASSIR N/A

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.